Risk factor
Good trading liquidity
Profitability factor
Strong margins and returns
About
Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of 301015.SZ is 27.3 and suggests 6.35% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen